Chase AIPricingFAQs
Display currency
Loading news…

Cyagen Biosciences

ActiveOperating status — whether the company still runs independently. “Closed” usually means it was acquired, merged, or shut down.🔥 HighHeat score — how much recent activity & attention the company has (web traffic, news, hiring).📈 Low growthGrowth score — momentum trend across web traffic, headcount and other growth signals.
Santa Clara, California, United States Founded 2005 501-1000 employees For Profit

Cyagen Biosciences specializes in genetically modified rodent models, cell, and gene therapy solutions for research and development.

Total Funding
Available in Pro
Last Funding
Available in Pro
Acquisitions
0
Monthly Visits
Available in Pro
Contacts
18

Company Details

Funding & Financials

Pro
Total funding
Funding rounds
Last funding
Last funding type
Last funding date
Funding status
Total equity funding
Revenue range

IPO & Stock

IPO status
Private

Web Traffic

Pro
Monthly visits
Global traffic rank
6-mo avg visits
Visit duration (s)
Pages / visit
Bounce rate
Rank change (mo)

Technology & IP

Active technologies
46
Active products
10
IT spend
$7M

Company Info

Founded
2005
Employees
501-1000
Operating status
Active
Company type
For Profit
Org types
company
Founders
1
News articles
9
Events
1
HQ
Santa Clara, California, United States
Region
San Francisco Bay Area, Silicon Valley, West Coast

Signals & Scores

Heat score
High
Growth score
Low
Trend (7d)
-0.1
Trend (30d)
2.6
Trend (90d)
1.8

Key People at Cyagen Biosciences

Founder & CEO
18
professional contacts at Cyagen Biosciences
Contact execs at Cyagen Biosciences

Explore 200,000+ acquisitions — free

Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.

Explore all acquisitions

Recent News related to Cyagen Biosciences

Loading news…

FAQs about Cyagen Biosciences

People who checked this page also checked these

Browse the full Acquirezy directory.
Cyagen Biosciences - Company Profile, Full Acquisitions List, Funding and Investments